Literature DB >> 26602028

A novel homozygous LMNA mutation (p.Met540Ile) causes mandibuloacral dysplasia type A.

Vahid Reza Yassaee1, Arash Khojaste2, Feyzollah Hashemi-Gorji3, Zeinab Ravesh4, Parviz Toosi5.   

Abstract

Mandibuloacral dysplasia with type A lipodystrophy (MADA) is a rare genetic disorder inherited in an autosomal recessive fashion characterized by hypoplasia of the mandible and clavicles, acroosteolysis and lipodystrophy due to mutations in the LMNA or ZMPSTE24 genes. In the current study, we have investigated a consanguineous family clinically diagnosed with mandibuloacral dysplasia type A having an affected child for the LMNA gene alteration(s). Mother is now 15weeks pregnant, seeking advice on the health of her fetus. Peripheral blood was obtained from all family members after informed consent was achieved. Genomic DNA was isolated. The sequence of the LMNA gene, including all exons and intron boundaries was analyzed by PCR and Sanger sequencing. Chorionic villus was collected from the placenta to reveal the condition of the fetus. Molecular analysis ascertained a homozygous mutation c.1620G>A (p.M540I) in the proband and heterozygous alteration in the family. Genomic DNA isolated from the CVS was amplified using specific primers for identified deleterious mutation and analyzed by Sanger sequencing. Two pathogenic mutations c.1620G>A and c.1698C>T were identified in the fetus. Genetic counseling as well as justified rapid and sensitive genetic testing can provide reassurance for the families to prevent the high burden of genetic disorders. We have also applied several online tools including PolyPhen2, MUpro, SIFT, PoPMuSiC, Project HOPE and Mutation Taster to predict the impact of p.Met540Ile substitution as a hotspot region within LMNA. All tools showed reduction in the stability of the protein structure. We conclude that p.M540I mutation may causes disease in the homozygous state.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Genetic counseling; Genetic testing; LMNA; Mandibuloacral dysplasia

Mesh:

Substances:

Year:  2015        PMID: 26602028     DOI: 10.1016/j.gene.2015.08.071

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  5 in total

Review 1.  Lamin A/C Mechanotransduction in Laminopathies.

Authors:  Francesca Donnaloja; Federica Carnevali; Emanuela Jacchetti; Manuela Teresa Raimondi
Journal:  Cells       Date:  2020-05-24       Impact factor: 6.600

2.  Mandibuloacral dysplasia type B (MADB): a cohort of eight patients from Suriname with a homozygous founder mutation in ZMPSTE24 (FACE1), clinical diagnostic criteria and management guidelines.

Authors:  M M Hitzert; S N van der Crabben; G Baldewsingh; H K Ploos van Amstel; A van den Wijngaard; C M A van Ravenswaaij-Arts; C W R Zijlmans
Journal:  Orphanet J Rare Dis       Date:  2019-12-19       Impact factor: 4.123

3.  Two Decades after Mandibuloacral Dysplasia Discovery: Additional Cases and Comprehensive View of Disease Characteristics.

Authors:  Isabelle Jéru; Amira Nabil; Gehad El-Makkawy; Olivier Lascols; Corinne Vigouroux; Ebtesam Abdalla
Journal:  Genes (Basel)       Date:  2021-09-26       Impact factor: 4.096

Review 4.  Nuclear envelopathies: a complex LINC between nuclear envelope and pathology.

Authors:  Alexandre Janin; Delphine Bauer; Francesca Ratti; Gilles Millat; Alexandre Méjat
Journal:  Orphanet J Rare Dis       Date:  2017-08-30       Impact factor: 4.123

Review 5.  Genomic instability and DNA replication defects in progeroid syndromes.

Authors:  Romina Burla; Mattia La Torre; Chiara Merigliano; Fiammetta Vernì; Isabella Saggio
Journal:  Nucleus       Date:  2018-06-23       Impact factor: 4.197

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.